• 2357 Citations
  • 27 h-Index
1987 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Pedro Miguel Lacal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
temozolomide Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Vascular Endothelial Growth Factor Receptor-1 Medicine & Life Sciences
Vascular Endothelial Growth Factor A Medicine & Life Sciences
Neuropilin-1 Medicine & Life Sciences
DNA Mismatch Repair Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2019

  • 2357 Citations
  • 27 h-Index
  • 72 Article
  • 2 Review article
3 Citations (Scopus)
Open Access
Vascular Endothelial Growth Factor A
Melanoma
Down-Regulation
MicroRNAs
Immunoblotting
7 Citations (Scopus)

Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid

Ceci, C., Lacal, P. M., Tentori, L., De Martino, M. G., Miano, R. & Graziani, G., Nov 14 2018, In : Nutrients. 10, 11, 1756.

Research output: Contribution to journalReview article

Ellagic Acid
ellagic acid
drug therapy
neoplasms
Fruit
3 Citations (Scopus)

Poly(ADP‑ribose) polymerase inhibitor olaparib hampers placental growth factor‑driven activation of myelomonocytic cells

Lacal, P. M., Atzori, M. G., Ruffini, F., Tentori, L. & Graziani, G., Jan 1 2018, In : Oncology Reports. 39, 5, p. 2261-2269 9 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor-1
Intercellular Signaling Peptides and Proteins
Growth
Monocytes
Extracellular Matrix
15 Citations (Scopus)
Vascular Endothelial Growth Factor Receptor-1
Cellular Microenvironment
Tumor Microenvironment
Vascular Endothelial Growth Factor Receptor-2
Vascular Endothelial Growth Factor A
3 Citations (Scopus)

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma

Abou Faycal, C., Brambilla, E., Agorreta, J., Lepeltier, N., Jacquet, T., Lemaître, N., Emadali, A., Lucas, A., Lacal, P. M., Montuenga, L., Pio, R., Gazzeri, S. & Eymin, B., Jun 1 2018, In : British Journal of Cancer. 118, 12, p. 1596-1608 13 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor-1
Integrins
Squamous Cell Carcinoma
Lung
Therapeutics